George D. Kalliolias

4.1k total citations · 1 hit paper
35 papers, 2.5k citations indexed

About

George D. Kalliolias is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, George D. Kalliolias has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in George D. Kalliolias's work include Cytokine Signaling Pathways and Interactions (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (5 papers). George D. Kalliolias is often cited by papers focused on Cytokine Signaling Pathways and Interactions (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (5 papers). George D. Kalliolias collaborates with scholars based in United States, Greece and France. George D. Kalliolias's co-authors include Lionel B. Ivashkiv, Stamatis‐Nick C. Liossis, Angela Lee, Rachael A. Gordon, Kyung‐Hyun Park‐Min, Antigoni Triantafyllopoulou, Yu Qiao, Ευγενία Γιαννοπούλου, Jane E. Salmon and Sung Ho Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Immunity.

In The Last Decade

George D. Kalliolias

34 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

2015 994 citations George D. Kalliolias, Lionel B. Ivashkiv Nature Reviews Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George D. Kalliolias United States	21	1.1k	779	484	449	236	35	2.5k
Dongyi He China	23	855 0.8×	833 1.1×	565 1.2×	347 0.8×	208 0.9×	42	2.3k
Linda K. Myers United States	31	1.4k 1.3×	651 0.8×	648 1.3×	430 1.0×	168 0.7×	102	3.2k
Guixiu Shi China	28	857 0.8×	759 1.0×	448 0.9×	314 0.7×	265 1.1×	122	2.4k
Jun‐Ki Min South Korea	35	1.1k 1.0×	848 1.1×	807 1.7×	352 0.8×	175 0.7×	80	2.6k
Kyoung‐Woon Kim South Korea	30	1.2k 1.1×	830 1.1×	827 1.7×	587 1.3×	252 1.1×	64	2.7k
Sander W. Tas Netherlands	33	1.4k 1.3×	923 1.2×	869 1.8×	498 1.1×	456 1.9×	118	3.4k
Akari Suzuki Japan	37	1.2k 1.1×	1.1k 1.4×	1.2k 2.4×	506 1.1×	362 1.5×	100	3.6k
Dong Hyun Sohn South Korea	18	722 0.6×	921 1.2×	468 1.0×	268 0.6×	171 0.7×	51	2.2k
Marietta Armaka Greece	26	1.1k 0.9×	1.2k 1.5×	840 1.7×	495 1.1×	378 1.6×	36	2.8k
Eleni Douni Greece	27	1.4k 1.2×	1.2k 1.5×	435 0.9×	635 1.4×	465 2.0×	58	3.2k

Countries citing papers authored by George D. Kalliolias

Since Specialization

Citations

This map shows the geographic impact of George D. Kalliolias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Kalliolias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Kalliolias more than expected).

Fields of papers citing papers by George D. Kalliolias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Kalliolias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Kalliolias. The network helps show where George D. Kalliolias may publish in the future.

Co-authorship network of co-authors of George D. Kalliolias

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Kalliolias. A scholar is included among the top collaborators of George D. Kalliolias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Kalliolias. George D. Kalliolias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalliolias, George D. & Athanasios G. Papavassiliou. (2024). Advancing precision rheumatology through tissue and blood profiling. Nature Reviews Rheumatology. 20(7). 391–392. 1 indexed citations

Wang, Claire Q., Sokol Haxhinasto, Sandra Garcet, et al.. (2022). Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. Journal of Investigative Dermatology. 143(1). 87–97.e14. 12 indexed citations

Kosloski, Matthew P., George D. Kalliolias, Christine Xu, et al.. (2021). Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials. Clinical and Translational Science. 15(2). 384–395. 35 indexed citations

Mun, Se Hwan, Seyeon Bae, Brian Oh, et al.. (2021). Augmenting MNK1/2 activation by c-FMS proteolysis promotes osteoclastogenesis and arthritic bone erosion. Bone Research. 9(1). 45–45. 8 indexed citations

Loh, Christopher, et al.. (2019). TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis. Annals of the Rheumatic Diseases. 78(9). 1205–1214. 75 indexed citations

Kuo, David, Upneet K. Sokhi, Ευγενία Γιαννοπούλου, et al.. (2017). Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. PLoS ONE. 12(7). e0179762–e0179762. 19 indexed citations

Kalliolias, George D. & Lionel B. Ivashkiv. (2015). TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nature Reviews Rheumatology. 12(1). 49–62. 994 indexed citations breakdown →

Donlin, Laura T., Arundathi Jayatilleke, Ευγενία Γιαννοπούλου, George D. Kalliolias, & Lionel B. Ivashkiv. (2014). Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts. The Journal of Immunology. 193(5). 2373–2383. 82 indexed citations

Chakravarty, Soumya D., Poulikos I. Poulikakos, Lionel B. Ivashkiv, Jane E. Salmon, & George D. Kalliolias. (2013). Kinase inhibitors: A new tool for the treatment of rheumatoid arthritis. Clinical Immunology. 148(1). 66–78. 25 indexed citations

10.

Lee, Angela, Yu Qiao, Janice Chen, et al.. (2013). Tumor Necrosis Factor α Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts. Arthritis & Rheumatism. 65(4). 928–938. 125 indexed citations

11.

Gordon, Rachael A., et al.. (2012). The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter‐regulated by the synovial fluid microenvironment. Arthritis & Rheumatism. 64(10). 3119–3128. 47 indexed citations

12.

Kalliolias, George D. & Lionel B. Ivashkiv. (2010). Overview of the biology of type I interferons. Arthritis Research & Therapy. 12(Suppl 1). S1–S1. 83 indexed citations

13.

Wang, Lu, Rachael A. Gordon, Jiahuai Han, et al.. (2010). Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins. Immunity. 32(4). 518–530. 111 indexed citations

14.

Kalliolias, George D. & Lionel B. Ivashkiv. (2009). Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation. F1000 Biology Reports. 1. 70–70. 4 indexed citations

15.

Kalliolias, George D. & Lionel B. Ivashkiv. (2008). IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38. The Journal of Immunology. 180(9). 6325–6333. 113 indexed citations

16.

Iconomou, Gregoris, Αngelos Koutras, Katerina Karaivazoglou, et al.. (2008). Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. European Journal of Cancer Care. 17(6). 535–41. 19 indexed citations

17.

Kalliolias, George D. & Stamatis‐Nick C. Liossis. (2008). The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis. Expert Opinion on Investigational Drugs. 17(3). 349–359. 84 indexed citations

18.

Sykiotis, Gerasimos P., George D. Kalliolias, & Athanasios G. Papavassiliou. (2005). Pharmacogenetic Principles in the Hippocratic Writings. The Journal of Clinical Pharmacology. 45(11). 1218–1220. 35 indexed citations

19.

Sykiotis, Gerasimos P., et al.. (2005). Of Temples and Plane Trees: the Hippocratic Legacy as Collective Memory. HORMONES. 4(1). 55–58.

20.

Sykiotis, Gerasimos P., George D. Kalliolias, & Athanasios G. Papavassiliou. (2005). Hippocrates and Genomic Medicine. Archives of Medical Research. 37(1). 181–183. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact